Nanomedicine approaches for treating glioblastoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Nanomedicine approaches for treating glioblastoma

Published:2023-08 Issue:18 Volume:18 Page:1135-1138
ISSN:1743-5889
Container-title:Nanomedicine
language:en
Short-container-title:Nanomedicine

Author:

Martins Cláudia¹²,Pacheco Catarina¹²³,Faria Paulo¹²⁴,Sarmento Bruno¹²³^ORCID

Affiliation:

1. i3S – Instituto de Investigação e Inovação em Saúde, Universidade do Porto, Rua Alfredo Allen 208, Porto, 4200-135, Portugal

2. INEB – Instituto de Engenharia Biomédica, Universidade do Porto, Rua Alfredo Allen 208, Porto, 4200-135, Portugal

3. IUCS-CESPU, Rua Central de Gandra 1317, Gandra, 4585–116, Portugal

4. ICBAS – Instituto de Ciências Biomédicas Abel Salazar, Universidade do Porto, Rua de Jorge Viterbo Ferreira 228, Porto, 4050–313, Portugal

Funder

Fundação para a Ciência e a Tecnologia

Horizon 2020 Framework Programme

Norte2020

Publisher

Future Medicine Ltd

Subject

Development,General Materials Science,Biomedical Engineering,Medicine (miscellaneous),Bioengineering

Link

https://www.futuremedicine.com/doi/pdf/10.2217/nnm-2023-0163

Reference19 articles.

1. Nanoparticles Loaded with Docetaxel and Resveratrol as an Advanced Tool for Cancer Therapy

2. Multi‐ligand functionalized blood‐to‐tumor sequential targeting strategies in the field of glioblastoma nanomedicine

3. Interleukin-13 receptor alpha 2 cooperates with EGFRvIII signaling to promote glioblastoma multiforme

4. Expression of Interleukin-13 Receptor α2 in Glioblastoma Multiforme: Implications for Targeted Therapies

5. EGFR Mutation Promotes Glioblastoma through Epigenome and Transcription Factor Network Remodeling

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP